With a clutch of vaccines on the way soon, equity markets were in a buoyant mood in November. But there are still a lot of things we don’t know – and even some things we don’t know that we don’t know…
This article makes the case for knowing what’s under the bonnet before investing in innovative new exchange-traded funds (ETFs).
Stock markets shot the lights out in November as news of promising vaccines hit the wires. The realities of distribution have lessened the glow a bit recently, leading investors to start reassessing their approach.
As demand for ESG investing continues, listen to this panel of industry experts discuss the overarching themes and impacts this is having on society, and investing in general.
Rather than try to reduce it by austerity, inflation or default, the government should focus on keeping the rate of economic growth above the cost of servicing the debt.
Writers have a notably solitary job, but has coronavirus curbed creativity? And how has the literary world adapted to the new normal?
Thanksgiving may be a super-spreader event this year, as governments around the world try to plan their way through the upcoming festive season. But investors have been given a boost from good vaccine news.
The Bank of England has recently added to its stimulus programme yet again, and it isn’t ruling out negative interest rates. But don’t believe the hype – it’s not yet ruling them in either.